PI3K targeting in breast cancer: the end of the beginning?

Lancet Oncol. 2016 Jun;17(6):696-697. doi: 10.1016/S1470-2045(16)00148-0. Epub 2016 May 4.

Authors

Thomas Bachelot¹, Mario Campone², Olivier Tredan³

Affiliations

¹ Centre Leon Berard, Medical Oncology, Lyon 69008, France. Electronic address: [email protected].
² Institut de Cancérologie de l'Ouest, Saint-Herblain, Nantes, France.
³ Centre Léon Bérard, Lyon, France.

PMID: 27155742
DOI: 10.1016/S1470-2045(16)00148-0

No abstract available

Publication types

Comment

MeSH terms

Breast Neoplasms*
Humans
Phosphatidylinositol 3-Kinases*
Proto-Oncogene Proteins c-akt

Substances

Phosphatidylinositol 3-Kinases
Proto-Oncogene Proteins c-akt